cVDPV2 暴发的实时预测模型:辅助暴发应对疫苗接种策略
研究开发了一种统计时空模型,用于预测地区级脊髓灰质炎病毒短期传播,纳入已知风险因素(历史野毒传播风险、常规免疫覆盖、人群免疫和暴露)。模型对2016年以来2型疫苗衍生脊髓灰质炎病毒传播的预测位置表现良好(AUC=0.96)。结论指出,随着2016年停用tOPV后2型免疫持续下降,新cVDPV2检出的应对需更快、范围更大,该模型可为决定疫苗接种反应规模提供定量依据。
要点
- 近期cVDPV2病例的邻近性是暴发传播的最强风险因素。
- 人群免疫、历史风险、常规免疫和环境监测与传播显著相关(p<0.05)。
- 模型预测cVDPV2病例位置良好(AUC=0.96),可辅助确定疫苗反应规模。
核心结论
- 随着2016年停用tOPV后2型免疫持续下降,对新cVDPV2检出的暴发应对需更快且范围更大。
- 该模型可为决定疫苗接种反应规模提供定量框架,但未涵盖所有需考虑的局部因素。
研究设计与样本
- 开发统计时空模型,纳入已知风险因素(历史野毒传播风险、常规免疫覆盖、人群免疫、暴露),预测地区级脊髓灰质炎病毒短期传播。
- 模型拟合2016年以来2型疫苗衍生脊髓灰质炎病毒传播数据,并用于估计当前暴发的应对范围。
主要发现
- 近期cVDPV2病例的邻近性是暴发传播的最强风险因素。
- 人群免疫、历史风险、常规免疫和环境监测与传播显著相关(p<0.05)。
- 模型预测cVDPV2病例位置良好(AUC=0.96)。
关键数值与推荐
- 模型预测cVDPV2病例位置的AUC=0.96。
- 人群免疫、历史风险、常规免疫和环境监测与传播的关联显著(p<0.05)。
临床怎么用
- 可用于新cVDPV2检出时辅助决定疫苗接种反应的适当规模。
- 需结合模型未涵盖的局部因素综合判断。
局限性
- 模型未考虑所有必须纳入整体疫苗接种反应的局部相关因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Circulating vaccine-derived poliovirus outbreaks are spreading more widely than anticipated, which has generated a crisis for the global polio eradication initiative. Effectively responding with vaccination activities requires a rapid risk assessment. This assessment is made difficult by the low case-to-infection ratio of type 2 poliovirus, variable transmissibility, changing population immunity, surveillance delays, and limited vaccine supply from the global stockpile. The geographical extent of responses have been highly variable between countries. METHODS: We develop a statistical spatio-temporal model of short-term, district-level poliovirus spread that incorporates known risk factors, including historical wild poliovirus transmission risk, routine immunization coverage, population immunity, and exposure to the outbreak virus. RESULTS: We find that proximity to recent cVDPV2 cases is the strongest risk factor for spread of an outbreak, and find significant associations between population immunity, historical risk, routine immunization, and environmental surveillance (p < 0.05). We examine the fit of the model to type 2 vaccine derived poliovirus spread since 2016 and find that our model predicts the location of cVDPV2 cases well (AUC = 0.96). We demonstrate use of the model to estimate appropriate scope of outbreak response activities to current outbreaks. CONCLUSION: As type 2 immunity continues to decline following the cessation of tOPV in 2016, outbreak responses to new cVDPV2 detections will need to be faster and larger in scope. We provide a framework that can be used to support decisions on the appropriate size of a vaccination response when new detections are identified. While the model does not account for all relevant local factors that must be considered in the overall vaccination response, it enables a quantitative basis for outbreak response size.
引用
- Voorman A, O'Reilly K, Lyons H, et al. Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies. Vaccine. 2021. PMID: 34483024. doi:10.1016/j.vaccine.2021.08.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。